Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 885 entries
View as:

The Asia-Pacific Flexible Dose Study of Dapoxetine and Patient Satisfaction in Premature Ejaculation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01063881 Org: User:
Start: 05/22/10 End: 06/14/11 Due: 06/14/12

A Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine (JNJ-64041575) Regimens in Hospitalized Infants and Children Aged 28 Days to 36 Months Infected With Respiratory Syncytial Virus

Phase: N/A Priority: Normal
NCT ID: NCT03333317 Org: User:
Start: 11/24/17 End: 03/23/18 Due: 03/23/19

The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) Trial

Phase: N/A Priority: Normal
NCT ID: NCT01081834 Org: User:
Start: 03/31/10 End: 03/31/12 Due: 03/31/13

A Study of EPI-7386 in Combination With Abiraterone Acetate Plus Prednisone, or Apalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC)

Phase: N/A Priority: Normal
NCT ID: NCT05295927 Org: User:
Start: 03/23/22 End: 09/30/22 Due: 09/30/23

A Study to Assess the Relative Oral Bioavailability of JNJ-63623872 Administered as Oral Concept Formulations Compared to the Current Tablet Formulation

Phase: N/A Priority: Normal
NCT ID: NCT02659735 Org: User:
Start: 12/31/15 End: 04/30/16 Due: 04/30/17

A Study to Assess the Pharmacokinetic Comparability of Guselkumab (CNTO1959) When Delivered by 2 Different Devices and as 2 Formulations in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT01866007 Org: User:
Start: 05/09/13 End: 10/09/13 Due: 10/09/14

Study in Women on the Effect of JNJ-64530440 on Oral Contraceptive and Midazolam, and the Effect of a High-fat Meal on JNJ-64530440

Phase: N/A Priority: Normal
NCT ID: NCT03890341 Org: User:
Start: 06/01/21 End: 11/01/21 Due: 11/01/22

A Crossover Study to Evaluate the Relative Oral Bioavailability and Food Effect After Single Dose Administration of JNJ-54861911 Tablet in Healthy Elderly Participants

Phase: N/A Priority: Normal
NCT ID: NCT02355561 Org: User:
Start: 01/31/15 End: 03/31/15 Due: 03/31/16

Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Oral Lumicitabine Regimens in Hospitalized Adult Participants Infected With Human Metapneumovirus

Phase: N/A Priority: Normal
NCT ID: NCT03502694 Org: User:
Start: 11/05/18 End: 10/28/20 Due: 10/28/21

A Study to Investigate Acute Respiratory Virus Infections in Participants at High Risk for Severe Illness

Phase: N/A Priority: Normal
NCT ID: NCT05661604 Org: User:
Start: 01/19/23 End: 03/31/24 Due: 03/31/25

A Study in Healthy Participants to Assess the Effect of Darunavir, Emtricitabine, and Tenofovir Alafenamide in the Presence of Cobicistat as Fixed Dose Combination (Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide) Compared With Co-administration of the Separate Agents

Phase: N/A Priority: Normal
NCT ID: NCT04661397 Org: User:
Start: 01/05/21 End: 07/02/21 Due: 07/02/22

A Study to Investigate the Effect of Different Particle Sizes on the Single-dose Pharmacokinetics of Rilpivirine After Intramuscular Injection of a Long-acting Nanosuspension in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03127189 Org: User:
Start: 04/20/17 End: 04/10/18 Due: 04/10/19

A Study of JNJ-64281802 Against Dengue Serotype 1 Infection in a Dengue Human Challenge Model in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT04480736 Org: User:
Start: 07/28/20 End: 12/09/27 Due: 12/09/28

A Study of CNTO 3157 in Healthy Normal and Asthmatic Participants Inoculated With Human Rhinovirus Type 16

Phase: N/A Priority: Normal
NCT ID: NCT01704040 Org: User:
Start: 10/31/12 End: 11/30/14 Due: 11/30/15

A Study of the Histone Deacetylase Inhibitor (HDACi) Quisinostat (JNJ-26481585) in Patients With Previously Treated Stage Ib-IVa Cutaneous T-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01486277 Org: User:
Start: 11/30/11 End: 07/31/16 Due: 07/31/17

A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01846611 Org: User:
Start: 10/16/13 End: 11/16/18 Due: 11/16/19

A Study of JNJ-64304500 Following Subcutaneous Injection in Healthy Chinese Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT04712006 Org: User:
Start: 05/30/21 End: 10/30/21 Due: 10/30/22

Study on Incidence of Diabetic Ketoacidosis Among Participants With Type 2 Diabetes Mellitus Treated With Sodium-glucose Co-transporter 2 (SGLT2) Inhibitors or Other Antihyperglycemic Agents

Phase: N/A Priority: Normal
NCT ID: NCT02636192 Org: User:
Start: 07/31/15 End: 04/07/17 Due: 04/07/18

A Study to Assess the Reversal of the Anticoagulant Effects of Milvexian by 4-Factor Prothrombin Complex Concentrate (4F-PCC) (Part 1) and Recombinant Human Factor VIIa (rFVIIa) (Part 2) in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04543383 Org: User:
Start: 07/27/20 End: 06/07/23 Due: 06/07/24

A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections

Phase: N/A Priority: Normal
NCT ID: NCT01110408 Org: User:
Start: 12/31/10 End: 06/30/13 Due: 06/30/14

A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02207231 Org: User:
Start: 11/26/14 End: 06/17/20 Due: 06/17/21

A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain

Phase: N/A Priority: Normal
NCT ID: NCT01165281 Org: User:
Start: 08/31/10 End: 08/31/12 Due: 08/31/13

A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate

Phase: N/A Priority: Normal
NCT ID: NCT01517802 Org: User:
Start: 03/28/12 End: 04/22/21 Due: 04/22/22

A Long Term Follow-up Study in Participants Treated in a Preceding Phase 2 or 3 Study With a Regimen Containing Odalasvir and AL-335 With or Without Simeprevir for the Treatment of Hepatitis C Virus (HCV) Infection

Phase: N/A Priority: Normal
NCT ID: NCT03099135 Org: User:
Start: 04/10/17 End: 02/13/18 Due: 02/13/19

A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 3

Phase: N/A Priority: Normal
NCT ID: NCT04985955 Org: User:
Start: 07/30/21 End: 09/21/21 Due: 09/21/22